Travere Therapeutics (NASDAQ:TVTX) climbed ~27% in the premarket on Wednesday after the company said that the FDA has informed it that an advisory committee meeting will not be necessary to review a ...
Aquestive Therapeutics (NASDAQ:AQST) added ~15% in the premarket on Thursday after announcing that the U.S. FDA has informed it that an advisory committee meeting will not be necessary in the review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback